Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
17.6% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
20
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.1% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
7
users have commented on this narrative
24
users have followed this narrative
9 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
4.7% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
IMCD
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Digitalization And M&A Will Expand Pharma And Consumer Markets
Key Takeaways Expansion into resilient end-markets and digitalization enhances operational efficiency, customer loyalty, and positions IMCD for sustained revenue and margin growth. Differentiated specialty offerings and industry outsourcing trends support long-term growth, while short-term disruptions are expected to ease as integration and diversification efforts bear fruit.
View narrative
€145.43
FV
35.8% undervalued
intrinsic discount
5.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
about 18 hours ago
author updated this narrative
Oberoi Realty
AN
AnalystConsensusTarget
Consensus Narrative from 23 Analysts
Mumbai Connectivity And Gurgaon Projects Will Unlock Opportunities
Key Takeaways Improving Mumbai infrastructure and demographic trends are set to boost demand and property values, supporting Oberoi Realty's long-term growth and premium positioning. Diversified pipelines through new projects, strong leasing of annuity assets, and disciplined land acquisitions enhance recurring income and protect margins.
View narrative
₹1.91k
FV
13.2% undervalued
intrinsic discount
31.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
about 18 hours ago
author updated this narrative
Yamaha Motor
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Integration Of OLV Business And Tech Advancements In Robotics And AI Will Improve Market Position
Key Takeaways Integrating the RV and golf car businesses into OLV aims for efficiency and cost reduction, enhancing revenue and operating income potential. Premiumization in Motorcycles and new products in emerging markets bolster revenue growth and profitability despite rising raw material costs.
View narrative
JP¥1.11k
FV
3.2% undervalued
intrinsic discount
4.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 18 hours ago
author updated this narrative
Eisai
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Alzheimer's Biomarker Adoption And Global Rollout Will Fuel Future Opportunity
Key Takeaways Rapid adoption of innovative Alzheimer's diagnostics and therapies, plus operational efficiencies, are expanding Eisai's eligible patient pool, driving revenue growth, and boosting profitability. Strong global rollout and premium market positioning for LEQEMBI support sustained demand, further diversification, and long-term earnings stability as the aging population increases.
View narrative
JP¥4.52k
FV
2.5% overvalued
intrinsic discount
3.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
about 18 hours ago
author updated this narrative
Banca Mediolanum
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Italian And Spanish Headwinds Will Erode Profit Margins
Key Takeaways Margin compression and slower revenue growth are likely due to lower-fee product shifts, increased regulation, and mounting competition from fintech and larger European players. Demographic headwinds in core markets may hinder organic asset growth, capping sustainable earnings and challenging fee-based revenue expansion.
View narrative
€17.11
FV
1.6% overvalued
intrinsic discount
-1.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
about 18 hours ago
author updated this narrative
Indian Bank
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Digital Platforms And Urban Branch Expansion Will Redefine Banking
Key Takeaways Robust digital investments and branch expansion into new regions drive customer growth, cost efficiency, and a broader lending and deposit base. Enhanced asset quality and low-cost deposit initiatives support margin resilience and predictability of earnings despite sectoral cost pressures.
View narrative
₹721.45
FV
7.0% undervalued
intrinsic discount
11.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
about 18 hours ago
author updated this narrative
Evonik Industries
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability
Key Takeaways Aggressive cost optimization and a shift to specialty chemicals are set to strengthen margins and align with rising demand for sustainable solutions. Expanded production in key plants and focus on healthcare, nutrition, and biopharma position the company for stable growth aided by regulatory and demographic trends.
View narrative
€20.57
FV
16.9% undervalued
intrinsic discount
1.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
20
users have followed this narrative
about 18 hours ago
author updated this narrative
Aurobindo Pharma
AN
AnalystConsensusTarget
Consensus Narrative from 28 Analysts
Biosimilars Expansion And EU Approvals Will Unlock Global Markets
Key Takeaways Expansion into biosimilars, specialty products, and US acquisitions is strengthening Aurobindo's portfolio, market access, and earnings potential. Increased manufacturing capacity, in-house production, and investment in complex generics support margin expansion, efficiency, and long-term growth.
View narrative
₹1.29k
FV
19.5% undervalued
intrinsic discount
7.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
20
users have followed this narrative
about 18 hours ago
author updated this narrative
Bid
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Expansion In South America, Europe, And Asia Will Drive Future Profitability
Key Takeaways Strategic acquisitions and expansion across continents position Bidcorp for revenue growth and improved profitability through diversified revenue streams. Focus on cost management and ESG initiatives aims to improve margins and boost bottom-line earnings despite external pressures.
View narrative
R500.73
FV
7.4% undervalued
intrinsic discount
6.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
about 18 hours ago
author updated this narrative
Value any company in seconds
Popular companies